{"id":50352,"date":"2020-07-05T22:22:58","date_gmt":"2020-07-05T22:22:58","guid":{"rendered":"https:\/\/www.nationaldrugscreening.com\/?post_type=faqs&#038;p=50352"},"modified":"2023-09-05T13:02:18","modified_gmt":"2023-09-05T18:02:18","slug":"does-dot-allow-electronic-custody-and-control-forms-for-required-dot-drug-testing","status":"publish","type":"faqs","link":"https:\/\/www.nationaldrugscreening.com\/faqs\/dot-drug-alcohol-testing-compliance\/does-dot-allow-electronic-custody-and-control-forms-for-required-dot-drug-testing\/","title":{"rendered":"Does DOT allow electronic custody and control forms for required DOT drug testing?"},"content":{"rendered":"\r\n<p>June 1, 2014 \u00a0&#8211;\u00a0Not currently but soon.<\/p>\r\n\r\n\r\n\r\n<p>May 29, 2014 &#8211; Last week, the Drug and Alcohol Testing Industry (DATIA merged with\u00a0<a href=\"https:\/\/ndasa.com\/\" target=\"_blank\" rel=\"noopener\">NDASA<\/a>\u00a0in 2023) put on an outstanding conference for professionals in the drug and alcohol industry.\u00a0 \u00a0<\/p>\r\n\r\n\r\n\r\n<p>The conference had record breaking attendance consisting of industry professionals, employers and DOT regulatory officials.\u00a0 Patrice Kelly, the Acting Director of the Office of Drug and Alcohol Policy and Compliance (ODAPC) in the Office of the Secretary of the U.S. Department of Transportation (DOT) provided an update on the DOT drug and alcohol testing program.\u00a0\u00a0<\/p>\r\n\r\n\r\n\r\n<p><strong>Breaking News<\/strong> &#8211; Kelly announced at the DATIA (now merged with\u00a0<a href=\"https:\/\/ndasa.com\/\" target=\"_blank\" rel=\"noopener\">NDASA<\/a>) conference that the Office of Management and Budget (OMB) has approved a rule to allow eCCFs for Federal Drug Testing Programs.\u00a0 The expectation is that the Office of Drug and Alcohol Policy and Compliance (ODAPC) will act quickly to pass a conforming rule to allow for use in DOT testing. Electronic Custody and Control forms (eCCF) will allow for the electronic processing of DOT and Federal drug testing. \u00a0\u00a0<\/p>\r\n","protected":false},"author":1,"template":"","acf":[],"_links":{"self":[{"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/faqs\/50352"}],"collection":[{"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/faqs"}],"about":[{"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/types\/faqs"}],"author":[{"embeddable":true,"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/users\/1"}],"version-history":[{"count":1,"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/faqs\/50352\/revisions"}],"predecessor-version":[{"id":118319,"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/faqs\/50352\/revisions\/118319"}],"wp:attachment":[{"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/media?parent=50352"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}